The Raiders put themselves in too many bad situations with penalties

The Company serves healthcare institutions, life scienceresearchers, clinical laboratories, industry and the general public. For moreinformation, please visit About Tyrian DiagnosticsTyrian Diagnostics (ASX:TDX) is a diagnostics company with expertise inbiomarker discovery and validation and diagnostic test development with a corefocus on respiratory and infectious diseases. Additional information about Tyrian Diagnostics can be found at Tyrian DiagnosticsDr Jenny Harry, 61 2 8877 8947Chief Executive OfficerorBlueprint Life Science GroupSabrina Antoniou, 61 400 788 277 or 61 2 9519 5537Investor Relations Copyright Business Wire 2009.

BURLINGTON, N.C.(Business Wire)Laboratory Corporation of America Holdings (LabCorp) (NYSE: LH) todayannounced that David P. King, Chief Executive Officer, is scheduled to speak atthe 27th Annual J.P. A live audio webcast of the presentation will be available via the Company Website at and archived for replay. About LabCorpLaboratory Corporation of America Holdings, a S&P 500 company, is a pioneer incommercializing new diagnostic technologies and the first in its industry toembrace genomic testing.

With annual revenues of $4.1 billion in 2007, over26,000 employees nationwide, and more than 220,000 clients, LabCorp offersclinical assays ranging from routine blood analyses to HIV and genomic testing.LabCorp combines its expertise in innovative clinical testing technology withits Centers of Excellence: The Center for Molecular Biology and Pathology,National Genetics Institute, Inc., ViroMed Laboratories, Inc., The Center forEsoteric Testing, Litholink Corporation, DIANON Systems, Inc., US LABS, andEsoterix and its Colorado Coagulation, Endocrine Sciences, and CytometryAssociates laboratories. LabCorp conducts clinical trial testing through itsEsoterix Clinical Trials Services division. To learn more about our organization, visit our Website at: Each of the above forward-looking statements is subject to change based onvarious important factors, including without limitation, competitive actions inthe marketplace and adverse actions of governmental and other third-partypayors.Actual results could differ materially from those suggested by theseforward-looking statements. Further information on potential factors that couldaffect LabCorps financial results is included in the Companys Form 10-K forthe year endedDecember 31, 2007, and subsequent SEC filings.LabCorpInvestor/Media Contact:Bill Bonello, 336-436-7732Company Information: Business Wire 2009. Oakland blew it hard today. There game against the Chiefs continued a trend that was hard to watch for Raider fans.Any hope the Raiders had of turning it around in the second half of the season slowly and dreadfully faded into oblivion at home against lowly Kansas City.Now we can officially declare over any false playoff hopes for Oakland. Their seventh-straight 10-loss season might as well be in the bag now, as well.In a game that Oakland should've won by at least 14 points, the Raiders failed to score for three straight quarters after starting the game on a roll with a 70-plus-yard touchdown drive set up by a Michael Bush 60-yard ramble that put the Raiders inside the Chiefs 5-yard line.JaMarcus Russell ended up getting pulled for the second time in the last four games and returning wide receiver Chaz Schilens was very much a non-factor in the loss.The Raiders put themselves in too many bad situations with penalties.